Bio-View Ltd

Equities

BIOV

IL0010960495

Advanced Medical Equipment & Technology

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 07:24:09 2024-04-25 am EDT			5-day change	1st Jan Change
29 ^ILa	0.00%		+1.05%	-11.85%

Mar. 27	Bio-View Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 27	Bio-View Ltd announces an Equity Buyback for ILS 0.7 million worth of its shares.	CI

Tranche Update on Bio-View Ltd's Equity Buyback Plan announced on November 30, 2022.

March 27, 2023 at 03:32 pm EDT

From November 29, 2022 to February 28, 2023, the company has repurchased 303,378 shares, representing 2.09% for ILS 1.13 million. With this, the company has completed the repurchase of 303,378 shares, representing 2.09% for ILS 1.13 million under the buyback announced on November 30, 2022.

Latest news about Bio-View Ltd

Bio-View Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Bio-View Ltd announces an Equity Buyback for ILS 0.7 million worth of its shares.	Mar. 27	CI
Bio-View Ltd authorizes a Buyback Plan.	Mar. 26	CI
Tranche Update on Bio-View Ltd's Equity Buyback Plan announced on March 27, 2023.	23-08-22	CI
Bio-View Ltd's Equity Buyback announced on March 27, 2023 has closed with 247,356 shares, representing 1.79% for ILS 0.87 million.	23-08-20	CI
Bio-View Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-14	CI
Bio-View Ltd announces an Equity Buyback for ILS 0.87 million worth of its shares.	23-03-27	CI
Tranche Update on Bio-View Ltd's Equity Buyback Plan announced on November 30, 2022.	23-03-27	CI
Bio-View Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-27	CI
Bio-View Ltd authorizes a Buyback Plan.	23-03-25	CI
Bio-View Ltdâ€™s Equity Buyback announced on November 30, 2022, has expired with 303,378 shares, representing 2.09% for ILS 1.13 million.	23-02-27	CI
Bio-View Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-26	CI

Chart Bio-View Ltd

Duration

Period

More charts

Company Profile

Bio View Ltd is an Israel-based laboratory equipment developer. The Company manufactures and assembles, markets and services an automated cell diagnostic system for use in cytology, cytogenetic, hematology and pathology laboratories. The workstation is called Duet, which provides automated detection, classification, analysis, and counting of cells for diagnosis and study. Additionally, Duet provides a method to analyze both the morphology and the genetic content of the same cell. The Company has applications in Cancer diagnosis and follow-up of minimal-residual disease (MRD); in pre-natal and post-natal Cytogenetic analyses in the analysis of sperm cells and rare-cell detection (RCD). In 2005, the Company introduced two new scanning workstations: the ALLEGRO, for automated scanning of Fluorescence in-situ Hybridization (FISH) probes without Brightfield scanning, and the ACCORD, for the semi-automated imaging of FISH for breast cancer (Her-2/Neu) and for FISH on tissue.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
BIO-VIEW LTD	-11.85%	10M
SARTORIUS AG	-12.42%	19.08B
QUIDELORTHO CORPORATION	-46.59%	2.65B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+17.50%	1.87B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-0.58%	1.61B
BIOTAGE AB	+25.36%	1.21B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-8.67%	1.02B
CONTEC MEDICAL SYSTEMS CO.,LTD	-21.91%	905M
REVENIO GROUP OYJ	-4.42%	716M
VAREX IMAGING CORPORATION	-17.51%	682M

Medical Diagnostic & Testing Equipment